Leo O'Connor[email protected]Financial ResultsLabcorp Q1 revenues drop 3% as base business growth surgesGrowth in the total Base Business, which excluded COVID-19 testing but included revenues from a lab management agreement with Ascension health system, was 19.8% compared to the Base Business in the prior year.April 27, 2023Mergers & AcquisitionsAs Q1 revenues slide, Quest inks deal to acquire liquid biopsy test developer Haystack OncologyTo acquire Haystack, the developer of a ctDNA-based test to detect MRD, Quest will pay $300 million in cash at closing and up to an additional $150 million on achieving future performance milestones.April 27, 2023Financial ResultsRoche, Thermo Fisher sales drop on diagnostic testing decline in Q1Thermo Fisher’s Life Sciences Solutions revenues declined 38% in Q1 compared to the prior-year quarter, but its Analytical Instruments revenues rose 13%.April 26, 2023Gene expressionRichele Test: Newsteasers cut off after they reach 3 lines - there isn't a pre-determined character count since characters can be various widthsApril 25, 2023Business InsightsWeek in Review: Abbott Q1 financial results | MDxHealth reimbursement | Meridian Bioscience FDA clearanceMDxHealth said Wednesday its Select mdx test for prostate cancer will now be reimbursed in the U.S. for Medicare patients who meet coverage conditions under a specific, foundational Local Coverage Determination (LCD).April 20, 2023Financial ResultsAbbott Q1 diagnostics sales decline, but CEO sees milder impact from pandemicThe impact of COVID-19 on its overall business “has rapidly and significantly lessened,” according to Abbott Chairman and CEO Robert Ford.April 19, 2023Business InsightsWeek in Review: Detecting disease with a blood drop | Oncocyte layoffs | Parkinson’s diagnosisResearchers in Spain have found that targeted testing for human immunodeficiency virus in hospital emergency departments holds potential for increasing diagnoses.April 13, 2023Financial ResultsOncocyte to lay off 20% of workforce in cost restructuringThe CEO said the layoff is part of a plan to bring its cost structure in line with its kitted product strategy and to optimize operational efficiency.April 13, 2023COVID-19Raisonance nabs BARDA contract to develop cough test to diagnose COVID-19, fluThe contract is for the continued development of the firm’s AudibleHealth Dx Diagnostic SaMD for COVID-19 and influenza through artificial intelligence-enabled cough analysis.April 12, 2023Business InsightsWeek in Review: The lack of data on early SARS-CoV-2 samples | LumiraDx layoff | Magellan former execs charged by DOJDuring the COVID-19 pandemic, healthcare providers nationwide administered an evolving array of monoclonal antibody treatments, previously untested on such a large scale. A study published Monday showed that this effort saved lives.April 6, 2023Previous PagePage 4 of 17Next PageTop StoriesFDA ClearanceAmgen gets FDA approval for small cell lung cancer therapyAmgen announced on Thursday that the U.S. Food and Drug Administration (FDA) has approved its therapy tarlatamab, to be marketed under the name Imdelltra, for the treatment of extensive-stage small cell lung cancer (ES-SCLC).Artificial IntelligenceBacklog of unresolved medical diagnoses leads to new method for clinical exome reanalysisStockT2 Biosystems to sell $8M in stock in private placementFDA Warning LetterFDA issues warning for Cue Health COVID-19 testsSponsor ContentVisit our Molecular Diagnostics Community